KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Merck (MRK) Equity Average (2016 - 2026)

Merck has reported Equity Average over the past 18 years, most recently at $49.3 billion for Q1 2026.

  • Quarterly Equity Average rose 3.98% to $49.3 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $49.3 billion through Mar 2026, up 3.98% year-over-year, with the annual reading at $49.5 billion for FY2025, 17.89% up from the prior year.
  • Equity Average was $49.3 billion for Q1 2026 at Merck, down from $52.3 billion in the prior quarter.
  • Over five years, Equity Average peaked at $52.3 billion in Q4 2025 and troughed at $39.0 billion in Q1 2024.
  • The 5-year median for Equity Average is $44.1 billion (2024), against an average of $44.6 billion.
  • Year-over-year, Equity Average skyrocketed 51.04% in 2022 and then fell 16.03% in 2024.
  • A 5-year view of Equity Average shows it stood at $45.3 billion in 2022, then fell by 12.86% to $39.5 billion in 2023, then increased by 15.2% to $45.5 billion in 2024, then increased by 14.93% to $52.3 billion in 2025, then decreased by 5.71% to $49.3 billion in 2026.
  • Per Business Quant, the three most recent readings for MRK's Equity Average are $49.3 billion (Q1 2026), $52.3 billion (Q4 2025), and $50.5 billion (Q3 2025).